Crossmark

NAD+ as a Target for Cancer Treatment

Crossref DOI link: https://doi.org/10.1007/978-3-030-80962-1_269-1

Published Online: 2023-03-03

Published Print: 2023

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Helman, Tessa

Braidy, Nady
License Information

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2023-01-01
More Information

Chapter History

Received: 25 July 2022, 00:00:00

Accepted: 2 August 2022, 00:00:00

First Online: 3 March 2023